X0306 4 2018-03-12 0 0001618835 Evofem Biosciences, Inc. EVFM 0001360000 Lynch Thomas G C/O EVOFEM BIOSCIENCES, INC. 12400 HIGH BLUFF DRIVE, SUITE 600 SAN DIEGO CA 92130 1 0 0 0 Stock option (right to buy) 7.29 2018-03-12 4 A 0 24691 0.00 A 2028-03-12 Common Stock 24691 24691 D Stock option (right to buy) 7.29 2018-03-12 4 A 0 225000 0.00 A 2028-03-12 Common Stock 225000 225000 D The shares of common stock exercisable pursuant to the option will vest in a series of thirty-six (36) successive equal monthly installments upon completion of each additional month of service for the Issuer measured from March 12, 2018. The option was awarded in connection with Mr. Lynch's board services. Mr. Lynch acquired a vested interest in one hundred twenty-five thousand (125,000) shares of common stock exercisable pursuant to the option effective as of March 12, 2018. The remaining shares shall vest in a series of twelve (12) successive equal monthly installments upon completion of each additional month of service for the Issuer measured from April 1, 2018. The option was awarded in connection with Mr. Lynch's consulting services provided to the Issuer. The options were granted subject to stockholder approval and will be forfeited if stockholder approval is not obtained within twelve months of the date of grant. /s/ Melanie Ruthrauff Levy, attorney-in-fact 2018-03-14